Serial 98924421

Live / Applied — First extension granted (statement of use) (as of 11 Mar 2026)

What this means for you

Not registered yet, but its 27 Dec 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
98924421
Mark type
Design / logo
Filed
27 Dec 2024
Published for opposition
22 Jul 2025
Attorney of record
Garth M. Dahlen

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical products, namely, blood products in the nature of proteins and protein preparations made from human blood, in particular, immunoglobulins and immunoglobulin preparations; Pharmaceutical products for preventing and treating immunological, neurological and hematological disorders; Pharmaceutical products for preventing and treating infectious diseases; Pharmaceutical products for preventing and treating autoimmune diseases; immunomodulatory, anti-inflammatory, anti-allergic, hyposensitizing and detoxifying or toxin-neutralizing medicines

Owner

Prosecution history

  • 12 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 11 Mar 2026 — SOU EXTENSION 1 GRANTED
  • 11 Mar 2026 — SOU EXTENSION 1 FILED
  • 11 Mar 2026 — SOU TEAS EXTENSION RECEIVED
  • 16 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 22 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 22 Jul 2025 — PUBLISHED FOR OPPOSITION
  • 16 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 16 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 16 Jun 2025 — EXAMINER'S AMENDMENT ENTERED
  • 16 Jun 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
  • 16 Jun 2025 — EXAMINERS AMENDMENT E-MAILED
  • 16 Jun 2025 — EXAMINERS AMENDMENT -WRITTEN
  • 10 Jun 2025 — ASSIGNED TO EXAMINER
  • 30 May 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED

View this trademark record on Marksy